Tectonic Therapeutic

About:

Tectonic Therapeutic is a biotechnology company which focuses on scientific research in biochemistry and molecular pharmacology.

Website: https://tectonictx.com/

Top Investors: Vida Ventures, Polaris Partners, Farallon Capital Management, 5AM Ventures, EcoR1 Capital

Description:

Tectonic is a privately held biotechnology company that aims to transform the discovery of novel GPCR-targeted drugs and unlock the therapeutic utility the most challenging receptors in the class. Tectonic’s founders are at the forefront of scientific research in biochemistry and molecular pharmacology with an extensive track record of entrepreneurial achievement.

Total Funding Amount:

$211M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Allston, Massachusetts, United States

Founded Date:

2020-02-01

Founders:

Andrew Krus, Timothy A. Springer

Number of Employees:

11-50

Last Funding Date:

2024-06-20

IPO Status:

Public

Industries:

© 2025 bioDAO.ai